MENS

Jyong Biotech Ltd.

• Reuters·3d ago

  Jyong Biotech files Form 3 showing CEO Fu-Feng Kuo as 10% owner

• Reuters·04/01 19:45

  Jyong Biotech files Form 3 as director Hsu Ming Tsan reports beneficial ownership

• Reuters·04/01 19:34

  Jyong Biotech files Form 3 as director Hsu Feng-Lin reports beneficial ownership

• Reuters·04/01 19:21

  Jyong Biotech director Hsu Feng-Lin files initial beneficial ownership statement

• Reuters·04/01 19:10

  Jyong Biotech files Form 3 initial beneficial ownership statement for director Fan Hung-Shu

• Reuters·04/01 18:57

  Jyong Biotech director Chi Pang-Chieh files initial beneficial ownership statement

• Reuters·03/27 12:30

  Jyong Biotech updates MCS-2 BPH/LUTS program; Phase III trials span 27 U.S. centers in 19 states

• Benzinga·02/25 21:07

  12 Health Care Stocks Moving In Wednesday's After-Market Session

• Benzinga·02/23 17:05

  12 Health Care Stocks Moving In Monday's Intraday Session

• Benzinga·02/12 13:55

  Jyong Biotech Completes Phase II Trial For MCS-8, Expands Commercial Presence In Asia

• TipRanks·02/12 13:35

  Jyong issues strategic corporate update, completes Phase II trial for MCS-8

• Reuters·02/12 13:30

  Jyong Biotech Reports Positive Phase II Results for MCS-8 in Prostate Cancer Prevention and Metabolic Health

• TipRanks·02/06 21:59

  Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial Officer

• Reuters·02/06 21:31

  Jyong Biotech Ltd. Appoints Wei Zhang as Chief Financial Officer

• Reuters·01/30 18:38

  BUZZ-U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer